The Securities and Exchange Commission (SEC) and the Food and Drug Administration (FDA) today announced a new Memorandum of Understanding (MOU) to bolster cooperation and ensure market integrity.
This agreement is designed to assist both agencies in carrying out their respective missions, fostering a more collaborative approach to oversight.